Interactive Brokers Advertisement
Home > Boards > US OTC > Alternative Energy >

United Health Products, Inc. (UEEC)

Add UEEC Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 12/15/2017 2:53:41 PM - Followers: 21 - Board type: Free - Posts Today: 1

United Health Products, Inc.


About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit:

UEEC Security Details
Share Structure
Market Value1 $16,300,445 a/o Jun 18, 2014
Shares Outstanding 102,647,640 a/o Apr 15, 2014
Float 82,554,000 a/o Dec 31, 2012
Authorized Shares 150,000,000 a/o Mar 31, 2013
Par Value No Par Value

Who we are...

United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze core technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the trauma, dental, dialysis, and veterinary markets.

We are customer driven. We distribute our products worldwide and support our partners with ideas and solutions that will help them manage the health and safety of the people they serve. United Health Products is based in Westbury, New York and
our common stock trades under the symbol “UEEC". More about our company...

What we do...

We produce HemoStyp®, a bio-absorbable sterile gauze that will promote hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding.

HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline without compromising coagulation.

HemoStyp® is available in multiple sizes and configurations
to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries;
post dialysis treatment; and puncture wounds.
More about our products...

HemoStyp® is a water soluable hemostatic gauze that will produce hemostasis almost instantly when placed on a cut or open wound.
It does not contain harmful chemicals or animal by-products and is FDA registered to help stop bleeding. Once bleeding has stopped, HemoStyp® is easily removed from the wound with water or saline solution without compromising hemostasis.

HemoStyp® is extremely effective, inexpensive, and easy to use.
It is hypoallergenic and bacteriostatic and is available in multiple sizes and configurations to suit various needs and applications.

United Health Products, Inc. (UEEC) was formed to develop, produce, and market proprietary wound care products. Our core technology is a hemostatic gauze that provides the means to control bleeding from cuts and open wounds with a cost effective, high efficiency product.

This innovative technology is derived from regenerated oxidized cellulose and marketed under the trade name HemoStyp®. It is an effective, all natural hemostatic agent registered with the FDA to help control bleeding from open wounds and body cavities.

HemoStyp® is available in multiple sizes and configurations to suit various market segments and, in a healthcare sector shifting toward providing high quality care at affordable cost, offers an appealing alternative to higher priced competitive products. In addition to general military and civilian applications, the company has recently introduced Hemostyp® to the sports medicine, veterinary, dental surgery and dialysis markets.

UEEC's Chairman and CEO, Dr. Phillip Forman, has over 30 years of experience in wound care management. He leads an experienced executive management team with proven ability to develop, integrate, and grow brands in the healthcare industry. Under Dr. Forman's leadership the company will focus on market expansion, distribution, and brand awareness through:

• New contracts and strategic partnerships
• Effectively targeted marketing and advertising
• Sales excellence
• Outstanding customer support
• Key acquisitions and
• Innovative product development

New Products

We have added new configuations of our patented hemostatic gauze to our product line. The products were developed to address the specific needs of new market segments and of our existing customers, including the U.S. Military. The new products include:

Dental Gauze for oral surgery,

Four versions of Trauma Gauze™ for battlefield trauma, and

Two island dressings to support intravenous procedures.

We expect tangible contributions from all of these products as well as from the cumulative effect of an expanded product line. We will continue to identify and develop new products and configurations as we explore new markets and inundate existing ones.


Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
UEEC News: Current Report Filing (8-k) 12/05/2017 08:01:31 AM
UEEC News: Quarterly Report (10-q) 11/14/2017 04:08:37 PM
UEEC News: Quarterly Report (10-q) 08/21/2017 04:33:23 PM
UEEC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/15/2017 02:50:55 PM
UEEC News: Quarterly Report (10-q) 07/31/2017 04:29:47 PM
#553   Profit taking but also maybe a need bottom rodman 12/15/17 02:53:41 PM
#552   Amazing up 37% in one day! And running rodman 12/14/17 04:20:17 PM
#551   JHOG just shear speculation and no hard data JMO! rodman 12/13/17 12:09:17 PM
#550   Help me on the math of a $2-4 JHOGG 12/13/17 11:43:56 AM
#549   Maybe NOT profit takers coming in. Good call Rod! rodman 12/13/17 09:23:04 AM
#548   I sold off 10000 shares at .49 thinking rodman 12/12/17 05:22:41 PM
#547   Revenues the 4th quarter 1 million+ JMO! rodman 12/12/17 02:56:39 PM
#546   Expected FDA decision? Aussie “FDA” 30 day? Which other important JHOGG 12/12/17 02:26:30 PM
#545   United Health Products Applying for Class III Designation Turbo_Trader72 12/12/17 10:28:04 AM
#544   Good plan watch for the selloff back down rodman 12/11/17 02:57:19 PM
#543   I've just got a small position in at Turbo_Trader72 12/11/17 12:59:15 PM
#542   I WOULDN'T LET IT RIDE THIS IS MORE rodman 12/11/17 12:40:05 PM
#541   .40 was my exit, but I'll hold on Turbo_Trader72 12/11/17 12:07:52 PM
#540   Great week up over 33% in one week. rodman 12/08/17 04:33:16 PM
#539   Review the projects with the US Military and rodman 12/06/17 09:04:52 AM
#538   Nice volume coming in, people taking notice... Turbo_Trader72 12/05/17 03:34:59 PM
#537   Watch for a sell off. Some day trader's rodman 12/05/17 10:15:14 AM
#536   Great point due it! I'll message Ihub as well! rodman 12/04/17 11:23:01 AM
#535   Great point due it! I'll message Ihub as well! rodman 12/04/17 11:23:01 AM
#534   Anyone know how to change what category this Turbo_Trader72 12/04/17 10:48:08 AM
#533   Thats cool! Just the beginning after the big rodman 12/04/17 10:38:22 AM
#532   This is all looking really really good! Turbo_Trader72 12/04/17 10:16:15 AM
#531   FDA Selects HemoStyp® for CtQ Pilot Program Turbo_Trader72 12/04/17 10:12:15 AM
#530   FDA has grant approval into the pilot program rodman 12/04/17 09:37:43 AM
#529   PR out for S. African market is another rodman 11/29/17 08:02:09 AM
#528   Anybody know when the next quarterly earning is SkiMan85 11/03/17 10:28:39 AM
#527   Careful with your sells the MM's want your rodman 11/01/17 02:44:21 PM
#526   If I could see the future I would rodman 10/18/17 09:34:30 AM
#524   Volume picking up lately... keeping a close Turbo_Trader72 10/17/17 03:07:43 PM
#523   UEEC hemostyp products are awaiting FDA approval for rodman 10/17/17 09:40:53 AM
#522   UEEC hemostyp products are awaiting FDA approval for rodman 10/17/17 09:40:53 AM
#521   Thats right! My contact tells me the CEO rodman 10/11/17 03:22:06 PM
#520   Thats right! My contact tells me the CEO rodman 10/11/17 03:22:06 PM
#519   It's interesting for sure. Have to wonder Turbo_Trader72 10/11/17 03:17:26 PM
#518   Saw it yesterday and the FDA application is rodman 10/11/17 03:10:50 PM
#517   News / PR is out, but it's not Turbo_Trader72 10/11/17 03:06:05 PM
#516   PR on their website as well - not Turbo_Trader72 10/11/17 03:04:15 PM
#515 Turbo_Trader72 10/11/17 11:53:53 AM
#514   That pr did state the 3rd quarter sales rodman 09/29/17 11:35:01 AM
#513   Does anyone know why SP has been moving SkiMan85 09/29/17 09:43:38 AM
#512   United Health Products..............PPS will move on Hemostyp FDA rodman 09/27/17 10:21:20 AM
#511   A lot of hype? No news? No pr's? rodman 09/18/17 11:31:45 AM
#510   UEEC is primed to receive brick and mortar rodman 09/14/17 09:22:06 AM
#509   Funny to see the vultures starting to smell rodman 09/07/17 09:38:33 AM
#508   Received my sample Hemostyp yesterday and was impressed rodman 08/31/17 09:24:25 AM
#507   Quiet before the storm! rodman 08/30/17 12:22:25 PM
#506   Man I would double down ASAP! The analyst rodman 08/28/17 08:51:59 AM
#505   Good stuff. Not sure we'll see an overnight michaelmcl 08/27/17 08:59:33 PM
#504   Heads up big week and should run after rodman 08/27/17 10:17:55 AM